Cargando…

Impact of Serum Apolipoprotein A-I on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer: a Propensity Score-Matched Analysis()

PURPOSE: We aimed to investigate the role of apolipoprotein A-I (ApoA-I) as a predictor of prognosis and treatment efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC) treated with first-line chemotherapy with or without bevacizumab. METHODS: We conducted a retrospective stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quan, Qi, Huang, Yuanyuan, Chen, Qi, Qiu, Huijuan, Hu, Qiaozhen, Rong, Yuming, Li, Tingwei, Xia, Liangping, Zhang, Bei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2017
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334545/ https://www.ncbi.nlm.nih.gov/pubmed/28292509 http://dx.doi.org/10.1016/j.tranon.2017.01.006

Ejemplares similares

Decreased apolipoprotein A-I level indicates poor prognosis in extranodal natural killer/T-cell lymphoma, nasal type
por: Quan, Qi, et al.
Publicado: (2016)

Glasgow PrognosticScore as a Predictor of BevacizumabEfficacy in the First-line Treatment with Metastatic Colorectal Cancer
por: Huang, Yuanyuan, et al.
Publicado: (2019)

Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer
por: Yin, Chenxi, et al.
Publicado: (2014)

Real-world effect of bevacizumab and eribulin on metastatic breast cancer using a propensity score matching analysis
por: Matsui, Koshi, et al.
Publicado: (2023)

The Efficacy of Bevacizumab in Different Line Chemotherapy for Chinese Patients with Metastatic Colorectal Cancer
por: Yin, Chenxi, et al.
Publicado: (2016)

Positive impact of the negative lymph node count on the survival rate of stage III colon cancer with pN1 and right-side disease
por: Quan, Qi, et al.
Publicado: (2019)

A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C
por: Liao, Fangxin, et al.
Publicado: (2015)

Immune Cell Infiltration of the Primary Tumor Microenvironment Predicted the Treatment Outcome of Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients
por: Wang, Yixing, et al.
Publicado: (2021)

The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study
por: Sun, Xue‐Song, et al.
Publicado: (2020)

Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer
por: Yang, Qiong, et al.
Publicado: (2015)

Effect of surgical margin on postoperative prognosis in patients with solitary hepatocellular carcinoma: A propensity score matching analysis
por: Zhou, Zewen, et al.
Publicado: (2021)

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study
por: Zhao, Chenghao, et al.
Publicado: (2023)

No significant relationship exists between tumor size and prognosis in distant metastatic hepatocellular carcinoma: a propensity score matching analysis based on SEER database
por: Xie, Jun, et al.
Publicado: (2022)

Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study
por: Sun, Xue-Song, et al.
Publicado: (2019)

Propensity score matching and complex surveys
por: Austin, Peter C, et al.
Publicado: (2016)

Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis
por: Qian, Bei, et al.
Publicado: (2022)

Role of palliative radiotherapy in unresectable intrahepatic cholangiocarcinoma: population-based analysis with propensity score matching
por: Shao, Feng, et al.
Publicado: (2018)

Effective Learning During COVID-19: Multilevel Covariates Matching and Propensity Score Matching
por: Guo, Siying, et al.
Publicado: (2022)

Correction: No significant relationship exists between tumor size and prognosis in distant metastatic hepatocellular carcinoma: a propensity score matching analysis based on SEER database
por: Xie, Jun, et al.
Publicado: (2022)

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
por: Rimini, M., et al.
Publicado: (2022)

Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
por: Guertin, Jason R., et al.
Publicado: (2016)

The Prognostic and Predictive Value of Carbohydrate Antigen 19-9 in Metastatic Colorectal Cancer Patients with First Line Bevacizumab Containing Chemotherapy
por: Jiang, Chang, et al.
Publicado: (2017)

Clinicopathological features and prognosis of young gastric cancer patients following radical gastrectomy: a propensity score matching analysis
por: Liu, Wu, et al.
Publicado: (2019)

Propensity Score-Matched Analysis of Laparoscopic versus Open Surgery for Non-Metastatic Rectal Cancer
por: Sakolprakaikij, Kanittha, et al.
Publicado: (2021)

Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis
por: Geng, Yiting, et al.
Publicado: (2016)

Preoperative systemic immune-inflammation index predicts prognosis of patients with non-metastatic renal cell carcinoma: a propensity score-matched analysis
por: Hu, Xu, et al.
Publicado: (2020)

Prognosis of papillary thyroid cancer in patients with Graves’ disease: a propensity score-matched analysis
por: Kwon, Hyungju, et al.
Publicado: (2020)

Comparison of Prognosis Between Juvenile and Adult Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis
por: Chen, Chuanben, et al.
Publicado: (2020)

Survival effects of primary and metastatic surgical treatment in metastatic small intestinal tumors: A propensity score–matching study
por: Zhou, Zhongyi, et al.
Publicado: (2022)

High C-reactive protein/albumin ratio predicts unfavorable distant metastasis-free survival in nasopharyngeal carcinoma: a propensity score-matched analysis
por: Wang, Yan, et al.
Publicado: (2018)

A Propensity Score-Matched Analysis for Non-Intubated Thoracic Surgery
por: Lan, Lan, et al.
Publicado: (2018)

First-line pemetrexed-platinum doublet chemotherapy with or without bevacizumab in non-squamous non-small cell lung cancer: A real-world propensity score-matched study in China
por: Qi, Fei, et al.
Publicado: (2019)

Propensity-score-matched evaluation of under-recognition of acute kidney injury and short-term outcomes
por: Wu, Buyun, et al.
Publicado: (2018)

Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis
por: Zhang, Jian Xi, et al.
Publicado: (2020)

Pregnancy Outcomes in Thyroid Cancer Survivors: A Propensity Score-Matched Cohort Study
por: Cao, Qi, et al.
Publicado: (2022)

A Retrospective Propensity Score Matched Study of the Preoperative C-Reactive Protein to Albumin Ratio and Prognosis in Patients with Resectable Non-Metastatic Breast Cancer
por: Zhou, Lin, et al.
Publicado: (2019)

Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study
por: Yao, Yi-Chen, et al.
Publicado: (2022)

Propensity score interval matching: using bootstrap confidence intervals for accommodating estimation errors of propensity scores
por: Pan, Wei, et al.
Publicado: (2015)

Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Niizeki, Takashi, et al.
Publicado: (2022)

Clinicopathologic Features and Prognosis of Female Early Breast Cancer With HER2 Low Expression: A Propensity Score Matched Analysis
por: Dai, Lanyi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jaiqkt57crsvka2d3c4n489ldi